Abstract
The gene for catechol-O-methyltransferase (COMT) plays a key modulatory role in dopaminergic and noradrenergic neurotransmission. Recent evidence suggests that modafinil, like other stimulants, might act through the dopaminergic system. We have reported a sexual dimorphism and a strong effect of the COMT genotype on narcolepsy symptoms and hypothesized that response to modafinil treatment may be associated with the COMT genotype. Here we confirm that COMT genotype distribution between men and women narcoleptics is associated with response to modafinil. In addition, the optimal daily dose of modafinil is approximately 100 mg lower in women narcoleptics and lower in all narcoleptics with low activity COMT genotype. Our results suggest that a sexual dimorphism in COMT activity affects the response to modafinil and probably to other dopaminergic stimulants.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 6 print issues and online access
$259.00 per year
only $43.17 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Nishino S, Mignot E . Pharmacological aspects of human and canine narcolepsy Prog Neurobiol 1997 52: 27–78
Dauvilliers Y, Neidhart E, Lecendreux M, Billiard M, Tafti M . MAO-A and COMT polymorphisms and gene effects in narcolepsy Mol Psychiatry 2001 6: 367–372
Bastuji H, Jouvet M . Successful treatment of idiopathic hypersomnia and narcolepsy with modafinil Prog Neuropsychopharmacol Biol Psychiatry 1988 12: 695–700
Billiard M, Besset A, Montplaisir J, Laffont F, Goldenberg F, Weill JS, Lubin S . Modafinil: a double-blind multicentric study Sleep 1994 17: S107–S112
US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil for the treatment of pathological somnolence in narcolepsy Ann Neurol 1998 43: 88–97
US Modafinil in Narcolepsy Multicenter Study Group. Randomized trial of modafinil as a treatment for the excessive daytime somnolence of narcolepsy Neurology 2000 54: 1166–1175
Lin JS, Hou Y, Jouvet M . Potential brain neuronal targets for amphetamine-, methylphenidate-, and modafinil-induced wakefulness, evidenced by c-fos immunocytochemistry in the cat Proc Natl Acad Sci U S A 1996 93: 14128–14133
Ferraro L, Antonelli T, Tanganelli S, O'Connor WT, Perez de la Mora M, Mendez-Franco J et al . The vigilance promoting drug modafinil increases extracellular glutamate levels in the medial preoptic area and the posterior hypothalamus of the conscious rat: prevention by local GABAA receptor blockade Neuropsychopharmacology 1999 20: 346–356
Engber TM, Dennis SA, Jones BE, Miller MS, Contreras PC . Brain regional substrates for the actions of the novel wake-promoting agent modafinil in the rat: comparison with amphetamine Neuroscience 1998 87: 905–911
Scammell TE, Estabrooke IV, McCarthy MT, Chemelli RM, Yanagisawa M, Miller MS et al . Hypothalamic arousal regions are activated during modafinil-induced wakefulness J Neurosci 2000 20: 8620–8628
Mignot E, Nishino S, Guilleminault C, Dement WC . Modafinil binds to the dopamine uptake carrier site with low affinity Sleep 1994 17: 436–437
Wisor JP, Nishino S, Sora I, Uhl GH, Mignot E, Edgar DM . Dopaminergic role in stimulant-induced wakefulness J Neurosci 2001 21: 1787–1794
Gorman SH . Determination of the D- and L-enantiomers of modafinil in human plasma utilizing liquid-liquid extraction and high-performance liquid chromatography J Chromatogr B Biomed Sci Appl 1999 25: 1–7
Wong YN, King SP, Simcoe D, Gorman S, Laughton W, McCormick GC et al . Open-label, single-dose pharmacokinetic study of modafinil tablets: influence of age and gender in normal subjects J Clin Pharmacol 1999 39: 281–288
Robertson P, DeCory HH, Madan A, Parkinson A . In vitro inhibition and induction of human hepatic cytochrome P450 enzymes by modafinil Drug Metab Dispos 2000 28: 664–671
Hagg S, Spigset O, Dahlqvist R . Influence of gender and oral contraceptives on CYP2D6 and CYP2C19 activity in healthy volunteers Br J Clin Pharmacol 2001 51: 169–173
Poolsup N, Li Wan Po A, Knight TL . Pharmacogenetics and psychopharmacotherapy J Clin Pharm Ther 2000 25: 197–220
Acknowledgements
We wish to thank the participants and their families. The work was supported by the Hôpitaux Universitaires de Genève (Geneva, Switzerland) and the Association pour l'Etude du Sommeil (Montpellier, France).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Dauvilliers, Y., Neidhart, E., Billiard, M. et al. Sexual dimorphism of the catechol-O-methyltransferase gene in narcolepsy is associated with response to modafinil. Pharmacogenomics J 2, 65–68 (2002). https://doi.org/10.1038/sj.tpj.6500088
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.tpj.6500088
Keywords
This article is cited by
-
How to Keep the Brain Awake? The Complex Molecular Pharmacogenetics of Wake Promotion
Neuropsychopharmacology (2009)
-
Pharmacogenetics of Modafinil After Sleep Loss: Catechol-O-Methyltransferase Genotype Modulates Waking Functions But Not Recovery Sleep
Clinical Pharmacology & Therapeutics (2009)
-
Association of narcolepsy-cataplexy with HLA-DRB1 and DQB1in Mexican patients: A relationship between HLA and gender is suggested
BMC Medical Genetics (2008)
-
Modafinil: A Review of Neurochemical Actions and Effects on Cognition
Neuropsychopharmacology (2008)